135 related articles for article (PubMed ID: 6224428)
41. Characterization of monocrotaline pyrrole-induced DNA cross-linking in pulmonary artery endothelium.
Wagner JG; Petry TW; Roth RA
Am J Physiol; 1993 May; 264(5 Pt 1):L517-22. PubMed ID: 8498528
[TBL] [Abstract][Full Text] [Related]
42. Pneumotoxicity and thrombocytopenia after single injection of monocrotaline.
Hilliker KS; Bell TG; Roth RA
Am J Physiol; 1982 Apr; 242(4):H573-9. PubMed ID: 6461260
[TBL] [Abstract][Full Text] [Related]
43. Monocrotaline-induced cardiopulmonary damage in rats: amelioration by the angiotensin-converting enzyme inhibitor CL242817.
Molteni A; Ward WF; Ts'ao CH; Solliday NH
Proc Soc Exp Biol Med; 1986 Sep; 182(4):483-93. PubMed ID: 3016747
[TBL] [Abstract][Full Text] [Related]
44. Supplemental oxygen reduces right ventricular hypertrophy in monocrotaline-injected rats.
Hill NS; Jederlinic P; Gagnon J
J Appl Physiol (1985); 1989 Apr; 66(4):1642-8. PubMed ID: 2525121
[TBL] [Abstract][Full Text] [Related]
45. COR pulmonale is caused by monocrotaline and dehydromonocrotaline, but not by glutathione or cysteine conjugates of dihydropyrrolizine.
Pan LC; Wilson DW; Lamé MW; Jones AD; Segall HJ
Toxicol Appl Pharmacol; 1993 Jan; 118(1):87-97. PubMed ID: 8430429
[TBL] [Abstract][Full Text] [Related]
46. Effects of bone marrow-derived cells on monocrotaline- and hypoxia-induced pulmonary hypertension in mice.
Raoul W; Wagner-Ballon O; Saber G; Hulin A; Marcos E; Giraudier S; Vainchenker W; Adnot S; Eddahibi S; Maitre B
Respir Res; 2007 Jan; 8(1):8. PubMed ID: 17263874
[TBL] [Abstract][Full Text] [Related]
47. The effects of monocrotaline pyrrole on cultured bovine pulmonary artery endothelial and smooth muscle cells.
Reindel JF; Roth RA
Am J Pathol; 1991 Mar; 138(3):707-19. PubMed ID: 2000943
[TBL] [Abstract][Full Text] [Related]
48. Effects of monocrotaline and monocrotaline pyrrole on 5-hydroxytryptamine and paraquat uptake by lung slices.
Hilliker KS; Garcia CM; Roth RA
Res Commun Chem Pathol Pharmacol; 1983 May; 40(2):179-97. PubMed ID: 6410470
[TBL] [Abstract][Full Text] [Related]
49. Monocrotaline-induced cardiopulmonary injury in rats: modification by thiol and nonthiol ACE inhibitors.
Molteni A; Ward W; Ts'ao C; Solliday N
Clin Exp Hypertens A; 1987; 9(2-3):381-5. PubMed ID: 3038399
[No Abstract] [Full Text] [Related]
50. An adult canine model of chronic pulmonary hypertension for cardiopulmonary transplantation.
Chen EP; Bittner HB; Tull F; Biswas SS; Davis RD; Van Trigt P
J Heart Lung Transplant; 1997 May; 16(5):538-47. PubMed ID: 9171273
[TBL] [Abstract][Full Text] [Related]
51. Single lung transplantation in rats with chemically induced pulmonary hypertension.
Kawaguchi AT; Mizuta T; Matsuda H; Shirakura R; Nakahara K; Tanaka H; Kawashima Y
J Thorac Cardiovasc Surg; 1992 Mar; 103(3):483-9. PubMed ID: 1532040
[TBL] [Abstract][Full Text] [Related]
52. Monocrotaline-induced cardiopulmonary injury in rats. Modification by the neutrophil elastase inhibitor SC39026.
Molteni A; Ward WF; Ts'ao CH; Hinz JM
Biochem Pharmacol; 1989 Aug; 38(15):2411-9. PubMed ID: 2547380
[TBL] [Abstract][Full Text] [Related]
53. Pathophysiology of infantile pulmonary arterial hypertension induced by monocrotaline.
Dias-Neto M; Luísa-Neves A; Pinho S; Gonçalves N; Mendes M; Eloy C; Lopes JM; Gonçalves D; Ferreira-Pinto M; Leite-Moreira AF; Henriques-Coelho T
Pediatr Cardiol; 2015 Jun; 36(5):1000-13. PubMed ID: 25608696
[TBL] [Abstract][Full Text] [Related]
54. Monokine-induced lung injury in rats: similarities to monocrotaline-induced pneumotoxicity.
Gillespie MN; Olson JW; Hennig B; Cohen DA; McClain CJ; Goldblum SE
Toxicol Appl Pharmacol; 1989 Mar; 98(1):134-43. PubMed ID: 2494779
[TBL] [Abstract][Full Text] [Related]
55. Altered pulmonary vascular smooth muscle responsiveness in monocrotaline-induced pulmonary hypertension.
Altiere RJ; Olson JW; Gillespie MN
J Pharmacol Exp Ther; 1986 Feb; 236(2):390-5. PubMed ID: 3080584
[TBL] [Abstract][Full Text] [Related]
56. Pulmonary vasculature in monocrotaline-induced hypertensive rats on magnesium therapy.
Mathew R; Gloster ES; Altura BT; Altura BM
Microcirc Endothelium Lymphatics; 1990; 6(4-5):267-83. PubMed ID: 2149161
[TBL] [Abstract][Full Text] [Related]
57. The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS.
Guerard P; Rakotoniaina Z; Goirand F; Rochette L; Dumas M; Lirussi F; Bardou M
Naunyn Schmiedebergs Arch Pharmacol; 2006 Sep; 373(6):401-14. PubMed ID: 16896805
[TBL] [Abstract][Full Text] [Related]
58. Pulmonary toxicity of monocrotaline differs at critical periods of lung development.
Todd L; Mullen M; Olley PM; Rabinovitch M
Pediatr Res; 1985 Jul; 19(7):731-7. PubMed ID: 3161000
[TBL] [Abstract][Full Text] [Related]
59. Chemical sympathectomy and serotonin inhibition reduce monocrotaline-induced right ventricular hypertrophy in rats.
Tucker A; Bryant SE; Frost HH; Migally N
Can J Physiol Pharmacol; 1983 Apr; 61(4):356-62. PubMed ID: 6222785
[TBL] [Abstract][Full Text] [Related]
60. Cardiac Body Surface Potentials in Rats with Experimental Pulmonary Hypertension during Ventricular Depolarization.
Suslonova OV; Smirnova SL; Roshchevskaya IM
Bull Exp Biol Med; 2016 Nov; 162(1):7-10. PubMed ID: 27878490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
